期刊
DRUG DISCOVERY TODAY
卷 17, 期 5-6, 页码 227-231出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2011.12.015
关键词
-
Recent changes to non-clinical cancer guidelines offer a golden opportunity to expedite the translation of new anticancer drugs into the clinic. In this review we look at how these guidelines can be implemented and how they can be integrated with non-clinical and clinical study design to produce robust and safe clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据